092730 — NeoPharm Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapSuper Stock

Annual balance sheet for NeoPharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	105,049	113,485	111,990	126,524	141,739
Net Total Accounts Receivable
Net Total Receivables	8,045	7,665	10,383	12,762	14,388
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	121,484	131,270	134,502	153,050	176,462
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9,743	9,341	29,244	29,764	30,184
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	143,408	155,347	177,459	192,440	217,811
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12,941	13,137	16,945	15,128	21,020
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	13,103	13,137	17,433	15,555	22,454
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	130,305	142,211	160,026	176,885	195,356
Total Liabilities & Shareholders' Equity	143,408	155,347	177,459	192,440	217,811
Total Common Shares Outstanding